- Investor Relations Asia Pacific

Golden Meditech Holdings Limited

Press Releases              

Please download the latest "Acrobat Reader" to view the PDF.

  • 2018-November-26
  • Golden Meditech Announces FY2018/2019 Interim Results (in PDF)
  • 2018-June-27
  • Golden Meditech Announces FY2017/2018 Annual Results (in PDF)
  • 2018-April-16
  • Golden Meditech's Associate, Cellenkos Names Alick Sun As Corporate & Business Development SVP (in PDF)
  • 2018-March-19
  • Golden Meditech's Largest Shareholder Further Increased Shareholdings (in PDF)
  • 2018-March-14
  • Golden Meditech's Largest Shareholder Acquired Additional 9,068,000 Shares (in PDF)
  • 2018-February-28
  • Golden Meditech's Subsidiary Completes Acquisition of 50% Equity Interest in ASA (in PDF)
  • 2018-February-26
  • Golden Meditech Lays Out Strategic Plan across the Value Chain in the Emerging Biomedical Industry (in PDF)
  • 2018-February-13
  • Golden Meditech Declares a Special Dividend to Shareholders (in PDF)
  • 2018-February-7
  • Golden Meditech Announces FDA Registration of GMP Manufacturing Facility by Its Associate, Cellenkos, Inc. (in PDF)
  • 2018-February-4
  • Golden Meditech Acquires 16.14% Interest of Ying Peng Hui Kang Fund (in PDF)
  • 2018-February-1
  • Golden Meditech Announces Close of Repurchase of TDR for the Delisting of TDR on TWSE (in PDF)
  • 2018-January-31
  • Golden Meditech Completes Sale of Equity Interest in China Cord Blood Corporation (in PDF)
  • 2017
  • 2017 Press Releases
  • 2016
  • 2016 Press Releases
  • 2015
  • 2015 Press Releases
  • 2014
  • 2014 Press Releases
  • 2013
  • 2013 Press Releases
  • 2012
  • 2012 Press Releases

  • Company's Index

  • About   |   Terms of Use   |   Disclaimer
    © Copyright 1996-2019 Ltd. All rights reserved.
    DISCLAIMER: Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall Ltd. be liable for damages resulting from the use of the information provided on this website.